• 3882 Citations
  • 32 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yoshinobu Maeda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 43 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient

Fujiwara, Y., Matsuoka, K. I., Iwamoto, M., Sumii, Y., Abe, M., Mizuhara, K., Urata, T., Saeki, K., Meguri, Y., Asada, N., Ennishi, D., Nishimori, H., Fujii, K., Fujii, N., Sugita, J., Kobayashi, H., Oto, T. & Maeda, Y., 2020, (Accepted/In press) In : International journal of hematology.

Research output: Contribution to journalArticle

  • Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

    Kayatani, H., Ohashi, K., Ninomiya, K., Makimoto, G., Nishii, K., Higo, H., Watanabe, H., Kano, H., Kato, Y., Ninomiya, T., Kubo, T., Rai, K., Ichihara, E., Hotta, K., Tabata, M., Maeda, Y. & Kiura, K., 2020, (Accepted/In press) In : Biochemical and Biophysical Research Communications. 532, 3, p. 341-346 6 p.

    Research output: Contribution to journalArticle

  • Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study

    Usui, Y., Ito, H., Koyanagi, Y., Shibata, A., Matsuda, T., Katanoda, K., Maeda, Y. & Matsuo, K., 2020, (Accepted/In press) In : International Journal of Cancer. 147, 11, p. 3102-3109 8 p.

    Research output: Contribution to journalArticle

  • Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors

    Ichihara, E., Harada, D., Inoue, K., Shibayama, T., Hosokawa, S., Kishino, D., Harita, S., Ochi, N., Oda, N., Hara, N., Hotta, K., Maeda, Y. & Kiura, K., 2020, (Accepted/In press) In : Cancer Immunology, Immunotherapy.

    Research output: Contribution to journalArticle

  • Open Access